Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer’s Disease: A Systematic Review
CNS Drugs · 2026-09 · 40 (9) · 1225-1241
DOI: 10.1007/s40263-026-01327-3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift CNS Drugs, online erschienen am 06.08.2026. Verfasst von Sirikalaya Brimson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, sigma, Neuroprotective Agents. Die Arbeit nennt 60 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.
- Siriraj Research Group in Immunobiology and Therapeutic Sciences, Research Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- College of Public Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
- Research, Innovation and International Affairs, Faculty Allied Health Sciences, Chulalongkorn University, 154 Rama 1 road, Chula-Phat-1 Bld. Soi Chula 12, Wangmai, Pathumwan, Bangkok, 10330, Thailand. jamesmichael.b@chu…
Zitieren
APA
Brimson, S., Thitilertdecha, P., Kumaree, K. K., & Brimson, J. M. (2026). Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer’s Disease: A Systematic Review. CNS Drugs, 40(9), 1225-1241. https://doi.org/10.1007/s40263-026-01327-3
Vancouver
Brimson S, Thitilertdecha P, Kumaree KK, Brimson JM. Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer’s Disease: A Systematic Review. CNS Drugs. 2026;40(9):1225-1241. doi:10.1007/s40263-026-01327-3
BibTeX
@article{Brimson2026,
author = {Brimson, Sirikalaya and Thitilertdecha, Premrutai and Kumaree, Kishoree Krishna and Brimson, James Michael},
title = {Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer’s Disease: A Systematic Review},
journal = {CNS Drugs},
year = {2026},
volume = {40},
number = {9},
pages = {1225--1241},
doi = {10.1007/s40263-026-01327-3}
}
EUVIMED